GAYLE DE MARIA
chimica oggi/Chemistry Today
gayle@teknoscienze.com

Bachem is an independent, technology-based, public biochemicals company providing full service to the pharma and biotech industry. The company is specialized in the process development and the manufacturing of peptides and complex organic molecules as active pharmaceutical ingredients (APIs), as well as innovative biochemicals for research purposes. It has more than 40 years of experience in peptide research and excellent know-how in peptide chemistry and organic synthesis. With headquarters in Bubendorf, Switzerland and affiliates in Europe and the US, Bachem works on a global scale and holds a leading position in the field of peptides.
Chimica Oggi / Chemistry Today journal took advantage of the changes in the top management of the company to interview the new CEO, dr Thomas Früh, and ask him to give us an overview of the products, services and technologies within the Bachem Group.

1. In 2011, Bachem celebrated its 40th year as a producer of research ingredients and active pharmaceutical ingredients (AP ... ...